SEC Form 4 · accession 0001127602-18-020138
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Louis W Sullivan
Director
Period of report
Jun 5, 2018
Accepted (ET)
Jun 6, 2018 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 5, 2018 | M | 15,000 | $51.77 | A | 16,750 | D | |
| Common Stock | Jun 5, 2018 | D | 15,000 | $108.50 | D | 1,750 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Tracking Award | $51.77 | Jun 5, 2018 | M | 15,000 | D | Jun 28, 2011 | Jun 28, 2020 | Common Stock | 15,000 | 0 | D |
Explanation of responses
- F1Exercise of a cash-settled share tracking award